GILEAD SCIENCES, INC. (GILD) FY2024 Q3 Balance Sheet

Balance Sheet

As of 2024-09-30

Swipe to see the full flow
GILEAD SCIENCES, INC. (GILD) FY2024 Q3 Balance SheetBalance sheet as of 2024-09-30. The chart shows assets, liabilities and equity at that date.Current liabilities$11.73 BLiabilities(calculated)$36.14 BCurrent assets$14.78 BAssets$54.53 BNon-current liabilities$24.41 BNon-current assets$39.75 BEquity$18.39 BHOLDINGSASSET CLASSASSETSCLAIM CLASSCLAIM SUB-CLASSCLAIMSCash and cash equivalentsAccounts receivable, netPrepaid and other current assetsInventoriesIntangible assets, netGoodwillOther long-term assetsProperty, plant and equipment, netOther current liabilitiesAccrued rebatesCurrent portion of long-term debt and other obligations, netAccounts payableLong-term debt, netOther long-term obligationsDeferred tax liabilityLong-term income taxes payableRetained earningsAdditional paid-in capitalAccumulated other comprehensive incomeCommon stock, par value $0.001 per share; 5,600 shares authorized; 1,246 shares issued and outstandingNoncontrolling interestCurrent assetsNon-current assetsAssetsCurrent liabilitiesNon-current liabilitiesLiabilities (calculated)EquityOther current liabilitiesOther current liabilities$4.90 BCurrent liabilitiesCurrent liabilities$11.73 BAccrued rebatesAccrued rebates$4.11 BLiabilities (calculated)Liabilities(calculated)$36.14 BCurrent portion of long-term debt and other obligations, netCurrent portion of long-termdebt and other obligations, net$1.81 BCash and cash equivalentsCash and cash equivalents$5.04 BCurrent assetsCurrent assets$14.78 BAccounts payableAccounts payable$903.00 MAssetsAssets$54.53 BAccounts receivable, netAccounts receivable, net$4.59 BNon-current liabilitiesNon-current liabilities$24.41 BPrepaid and other current assetsPrepaid and other current assets$3.29 BLong-term debt, netLong-term debt, net$21.44 BInventoriesInventories$1.87 BNon-current assetsNon-current assets$39.75 BOther long-term obligationsOther long-term obligations$1.40 BIntangible assets, netIntangible assets, net$20.55 BDeferred tax liabilityDeferred tax liability$794.00 MLong-term income taxes payableLong-term income taxes payable$782.00 MEquityEquity$18.39 BGoodwillGoodwill$8.31 BRetained earningsRetained earnings$11.07 BOther long-term assetsOther long-term assets$5.49 BProperty, plant and equipment, netProperty, plant and equipment, net$5.39 BAdditional paid-in capitalAdditional paid-in capital$7.33 BAccumulated other comprehensive incomeAccumulated other comprehensive income$73.00 MCommon stock, par value $0.001 per share; 5,600 shares authorized; 1,246 shares issued and outstandingCommon stock$1.00 MNoncontrolling interestNoncontrolling interest−$84.00 M
Chart details

GILEAD SCIENCES, INC. (GILD) FY2024 Q3 Balance Sheet

Balance sheet as of 2024-09-30. The chart shows assets, liabilities and equity at that date.

Assets
54,525,000,000 US dollars
Current assets
14,779,000,000 US dollars
Non-current assets
39,746,000,000 US dollars
Liabilities (calculated)
36,135,000,000 US dollars
Current liabilities
11,725,000,000 US dollars
Non-current liabilities
24,410,000,000 US dollars
Equity
18,390,000,000 US dollars
Noncontrolling interest
negative 84,000,000 US dollars. Included in consolidated equity; this amount is not added again.
Cash and cash equivalents
5,037,000,000 US dollars
Accounts receivable, net
4,587,000,000 US dollars
Prepaid and other current assets
3,287,000,000 US dollars
Inventories
1,869,000,000 US dollars
Short-term marketable debt securities
0 US dollars
Intangible assets, net
20,546,000,000 US dollars
Goodwill
8,314,000,000 US dollars
Other long-term assets
5,494,000,000 US dollars
Property, plant and equipment, net
5,391,000,000 US dollars
Long-term marketable debt securities
0 US dollars
Other current liabilities
4,896,000,000 US dollars
Accrued rebates
4,113,000,000 US dollars
Current portion of long-term debt and other obligations, net
1,812,000,000 US dollars
Accounts payable
903,000,000 US dollars
Long-term debt, net
21,437,000,000 US dollars
Other long-term obligations
1,396,000,000 US dollars
Deferred tax liability
794,000,000 US dollars
Long-term income taxes payable
782,000,000 US dollars
Retained earnings
11,073,000,000 US dollars
Additional paid-in capital
7,327,000,000 US dollars
Accumulated other comprehensive income
73,000,000 US dollars
Common stock, par value $0.001 per share; 5,600 shares authorized; 1,246 shares issued and outstanding
1,000,000 US dollars
Preferred stock, par value $0.001 per share; 5 shares authorized; none outstanding
0 US dollars
Noncontrolling interest
negative 84,000,000 US dollars

Chart connections

  • Assets equal liabilities plus consolidated equity. Consolidated equity includes noncontrolling interests when reported.
  • Treasury shares and other negative equity contributions reduce equity.
  • The filed current assets lines add up to $14,780.00 M and the current assets total is $14,779.00 M; the $1.00 M difference is within the rounding of the filed amounts.
  • The filed non-current assets lines add up to $39,745.00 M and the non-current assets total is $39,746.00 M; the $1.00 M difference is within the rounding of the filed amounts.
  • The filed current liabilities lines add up to $11,724.00 M and the current liabilities total is $11,725.00 M; the $1.00 M difference is within the rounding of the filed amounts.
  • The filed non-current liabilities lines add up to $24,409.00 M and the non-current liabilities total is $24,410.00 M; the $1.00 M difference is within the rounding of the filed amounts.
GILEAD SCIENCES, INC. (GILD) FY2024 Q3 Balance Sheet Sankey chart
Free to share unchanged, with credit to Plicit.ai · CC BY-NC-ND 4.0Download PNG

Newsletter

Get the teardowns by email

Subscribe if you want the public-company teardowns in your inbox when they're released.

Product waitlist

Health Check and Teardown for your own company

A health check uncovers insights of your private books, not a public ticker. Join this list to get notified as soon as we go-live!